Tuesday, 21 July 2026European Markets

#drug licensing

1 article

Tafoxiparin Licensing Deal Faces EU Approval Uncertainty as Exeltis Awaits Market Authorization

EU Pharmaceutical Regulation

Tafoxiparin Licensing Deal Faces EU Approval Uncertainty as Exeltis Awaits Market Authorization

ViaNews Editorial Team (Europe)•Feb 21, 2026